Skip to content

Cash ratio at other companies

Rogers Corporation logo
Rogers CorporationROG
1.5×+0.2×
Vera Therapeutics logo
Vera TherapeuticsVERA
2.5×0.0×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
1.3×+0.6×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.5×+0.1×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
1.9×+0.4×
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
1.2×-0.4×

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's cash ratio?
Aurinia Pharmaceuticals (AUPH) reported cash ratio of 0.5× in Q1 2026.
How has Aurinia Pharmaceuticals's cash ratio changed year-over-year?
Aurinia Pharmaceuticals's cash ratio decreased by 51.2% year-over-year, from 1× to 0.5×.
What is the long-term trend for Aurinia Pharmaceuticals's cash ratio?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's cash ratio has grown at a -36.8% compound annual growth rate (CAGR), from 8.5× to 0.9×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.